Evotec AG has made a €15 million equity investment in Exscientia Ltd which is developing artificial intelligence technologies to aid drug discovery. The German company already has a research collaboration with Exscientia dating from 2016. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
